Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 1:9:376.
doi: 10.3389/fimmu.2018.00376. eCollection 2018.

Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense

Affiliations
Review

Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense

Piera Valenti et al. Front Immunol. .

Abstract

The innate defense system of the female mucosal genital tract involves a close and complex interaction among the healthy vaginal microbiota, different cells, and various proteins that protect the host from pathogens. Vaginal lactobacilli and lactoferrin represent two essential actors in the vaginal environment. Lactobacilli represent the dominant bacterial species able to prevent facultative and obligate anaerobes outnumber in vaginal microbiota maintaining healthy microbial homeostasis. Several mechanisms underlie the protection exerted by lactobacilli: competition for nutrients and tissue adherence, reduction of the vaginal pH, modulation of immunity, and production of bioactive compounds. Among bioactive factors of cervicovaginal mucosa, lactoferrin, an iron-binding cationic glycoprotein, is a multifunctional glycoprotein with antibacterial, antifungal, antiviral, and antiparasitic activities, recently emerging as an important modulator of inflammation. Lactobacilli and lactoferrin are largely under the influence of female hormones and of paracrine production of various cytokines. Lactoferrin is strongly increased in lower genital tract mucosal fluid of women affected by Neisseria gonorrheae, Chlamydia trachomatis, and Trichomonas vaginalis infections promoting both innate and adaptive immune responses. In vaginal dysbiosis characterized by low amounts of vaginal lactobacilli and increased levels of endogenous anaerobic bacteria, the increase in lactoferrin could act as an immune modulator assuming the role normally played by the healthy microbiota in vaginal mucosa. Then lactoferrin and lactobacilli may be considered as biomarkers of altered microbial homeostasis at vaginal level. Considering the shortage of effective treatments to counteract recurrent and/or antibiotic-resistant bacterial infections, the intravaginal administration of lactobacilli and lactoferrin could be a novel efficient therapeutic strategy and a valuable tool to restore mucosal immune homeostasis.

Keywords: cervicovaginal defense; inflammation; lactobacilli; lactoferrin; vaginal homeostasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison among estrogen, progesterone, and Lactoferrin levels.
Figure 2
Figure 2
Lactobacillus spp. and lactoferrin interplay on infection and inflammation in female genital tract. A schematic representation of Lactobacillus spp. and lactoferrin balance: a multitasking strategy to protect against pathogen challenge and maintain immune homeostasis. (A) Healthy genital tract; (B) vaginosis: high levels of pro-inflammatory cytokines, decrease of lactobacilli and increase of Gram-negative anaerobes, and increase of lactoferrin concentration released by neutrophils; (C) decrease of pro-inflammatory cytokines by lactoferrin and restoration of healthy microbiota.

References

    1. Rampersauda R, Randis TM, Ratner AJ. Microbiota of the upper and lower genital tract. Semin Fetal Neonatal Med (2012) 17:51–7.10.1016/j.siny.2011.08.006 - DOI - PMC - PubMed
    1. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis (1990) 12(5):856–72.10.1093/clinids/12.5.856 - DOI - PubMed
    1. Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clin Infect Dis (2001) 32(4):e69–77.10.1086/318710 - DOI - PubMed
    1. Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 185(9):1307–13.10.1086/339884 - DOI - PubMed
    1. Srinivasan S, Fredricks DN. The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2008) 2008:750479.10.1155/2008/750479 - DOI - PMC - PubMed

Publication types

LinkOut - more resources